-Aker Biomarine moves to profit of NOK178m in 2010 on one-off gain.(Financial report)(Brief article) - Nordic Business Report

18 February 2011 - Norwegian krill oil company Aker Biomarine ASA (OSL: AKBM) turned to a net profit of NOK178m in 2010 from a year-earlier loss of NOK304m, buoyed by a NOK393m gain on the sale of a stake in a unit.

'The year was Aker Biomarine's best so far,' the company said in its statement today.

Revenues more that doubled to NOK311m from NOK141m, as sales of krill oil, used for its health benefits, under the Superba brand tripled.

The company also reported for the first time positive EBITDA of NOK 20m, versus a loss of NOK130m in 2009.

Aker Biomarine considers that it is well-positioned for further growth in all markets.

In November, the company completed the sale of a 50% stake in its subsidiary Trygg Pharma Holding, owning the unit Natural Nutrition Development AS. The buyer is US private equity firm Lindsay Goldberg LLC.

(EUR1 = NOK7.8)

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDFebruary 18, 2011>JNNORDIC BUSINESS REPORT.PRICEDATENOT APPLICABLE.DAY